Results of a prospective clinical trial for VAMP alone without irradiation for pediatric favorable, early-stage Hodgkin lymphoma patients who achieve an early complete response.
Monika L. Metzger(St. Jude Children's Research Hospital), MP Link, Sarah S. Donaldson(Stanford University), Eric Larsen(University of Massachusetts Chan Medical School), Amy L. Billett(Harvard University Press), Joanne Wu, Harel Weinstein(Cornell University), Catherine A. Billups(St. Jude Children's Research Hospital), Melissa M. Hudson(Cincinnati Children's Hospital Medical Center), Alison M. Friedmann(Harvard University), N J Tarbell, Karen Marcus(Boston Children's Museum), Matthew J. Krasin(St. Jude Children's Research Hospital), Torunn I. Yock(Massachusetts General Hospital)
Cited by 1
Related Papers
Chronic Health Conditions in Adult Survivors of Childhood Cancer
|New England Journal of Medicine|2006|3.6k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k